1
Total deals
$6.7B
Total value
$6.7B
Avg deal
$6.7B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Terns Pharmaceuticals
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases inc…
|
2026-03-24 | Acquisition | Pending | $6.7B | Deal → |